John Tan

China Introduces A New Regulatory Data Protection And Exclusivity Mechanism

Chinese Regulators Launch Investigation Of Former Healthcare Official

President Trump Presses Pause On FCPA Enforcement — But Bribery Is Still Illegal And Compliance Programs Still Matter

China Life Sciences: 2024 Year In Review

Chinese Regulators Publish Final Anti-Corruption Guidelines For The Healthcare Industry

China's New Draft Administrative Measures For Management Of Medical Representatives

The New Draft Administrative Measures For Management Of Medical Representatives

Landmark Whistleblower Program For China's Healthcare Sector

Landmark Whistleblower Program For China's Healthcare Sector: Proposed Maximum Reward Of 1 Million RMB

China's First Official Anti-Corruption Guidance For The Healthcare Industry